Envestnet Portfolio Solutions, Inc. Exact Sciences Corp Transaction History
Envestnet Portfolio Solutions, Inc.
- $27.8 Billion
- Q4 2024
A detailed history of Envestnet Portfolio Solutions, Inc. transactions in Exact Sciences Corp stock. As of the latest transaction made, Envestnet Portfolio Solutions, Inc. holds 17,819 shares of EXAS stock, worth $817,713. This represents 0.0% of its overall portfolio holdings.
Number of Shares
17,819
Previous 19,925
10.57%
Holding current value
$817,713
Previous $1.36 Million
26.18%
% of portfolio
0.0%
Previous 0.0%
Shares
6 transactions
Others Institutions Holding EXAS
# of Institutions
672Shares Held
164MCall Options Held
4.25MPut Options Held
1.89M-
Capital World Investors Los Angeles, CA17.5MShares$805 Million0.16% of portfolio
-
Vanguard Group Inc Valley Forge, PA17MShares$781 Million0.02% of portfolio
-
Black Rock Inc. New York, NY12.1MShares$554 Million0.01% of portfolio
-
Wellington Management Group LLP Boston, MA12.1MShares$553 Million0.13% of portfolio
-
State Street Corp Boston, MA6.23MShares$286 Million0.01% of portfolio
About EXACT SCIENCES CORP
- Ticker EXAS
- Exchange NASDAQ
- Sector Healthcare
- Industry Diagnostics & Research
- Shares Outstandng 176,960,000
- Market Cap $8.12B
- Description
- Exact Sciences Corporation provides cancer screening and diagnostic test products in the United States and internationally. The company offers Cologuard, a non-invasive stool-based DNA screening test to detect DNA and hemoglobin biomarkers associated with colorectal cancer and pre-cancer. It also provides Oncotype DX, a gene expression tests for...